Details
Stereochemistry | EPIMERIC |
Molecular Formula | C28H38NO4 |
Molecular Weight | 452.6056 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 5 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
CCCCOC1=CC=C(C[N@+]2(C)[C@H]3CC[C@@H]2C[C@@H](C3)OC(=O)[C@H](CO)C4=CC=CC=C4)C=C1
InChI
InChIKey=ALVDDLOWVXJXCD-OTSXCXJCSA-N
InChI=1S/C28H38NO4/c1-3-4-16-32-25-14-10-21(11-15-25)19-29(2)23-12-13-24(29)18-26(17-23)33-28(31)27(20-30)22-8-6-5-7-9-22/h5-11,14-15,23-24,26-27,30H,3-4,12-13,16-20H2,1-2H3/q+1/t23-,24+,26+,27-,29?/m1/s1
Molecular Formula | C28H37NO4 |
Molecular Weight | 451.5977 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including http://www.mims.com/malaysia/drug/info/coliopan and http://www.genome.jp/dbget-bin/www_bget?D01491
Curator's Comment: Description was created based on several sources, including http://www.mims.com/malaysia/drug/info/coliopan and http://www.genome.jp/dbget-bin/www_bget?D01491
Butropium Bromide is an anticholinergic and an antispasmodic. It is a Muscarinic receptor antagonist. The drug is used for remission of spasmodic pain in the following diseases: gastritis, enteritis, gastric ulcer, duodenal ulcer, cholelithiasis and cholecystopathy (including cholecystitis, and cholecystic and biliary dyskinesia). It is marketed in Japan under the brand name Coliopan.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 Sources: http://www.genome.jp/dbget-bin/www_bget?D01491 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Coliopan Approved UseRemission of spasmodic pain in the following diseases: Gastritis, enteritis, gastric ulcer, duodenal ulcer, cholelithiasis
and cholecystopathy (including cholecystitis, and cholecystic and biliary dyskinesia) Launch Date1974 |
|||
Palliative | Coliopan Approved UseRemission of spasmodic pain in the following diseases: Gastritis, enteritis, gastric ulcer, duodenal ulcer, cholelithiasis
and cholecystopathy (including cholecystitis, and cholecystic and biliary dyskinesia) Launch Date1974 |
|||
Palliative | Coliopan Approved UseRemission of spasmodic pain in the following diseases: Gastritis, enteritis, gastric ulcer, duodenal ulcer, cholelithiasis
and cholecystopathy (including cholecystitis, and cholecystic and biliary dyskinesia) Launch Date1974 |
PubMed
Title | Date | PubMed |
---|---|---|
Effect of glucagon on gastric motility examined by the acetaminophen absorption method and the endoscopic procedure. | 1985 |
|
Sensation of aural fullness and its treatment with an autonomic nerve blocking agent. | 1987 |
|
Endoscopic manometry of the sphincter of Oddi in dogs. Pharmacological effects of anticholinergic and selective antimuscarinic agents. | 1987 May |
Patents
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Can also be administered intramuscularly http://www.ncbi.nlm.nih.gov/pubmed/7182948
Capsules 5 mg:
The usual adult dosage for oral use is 6 capsules (30 mg of
butropium bromide) daily in three divided doses.
Tablets 10 mg:
The usual adult dosage for oral use is 3 tablets (30 mg of
butropium bromide) daily in three divided doses.
Granules 2 %:
The usual adult dosage for oral use is 1.5 g (30 mg of
butropium bromide) daily in three divided doses.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:08:47 GMT 2023
by
admin
on
Fri Dec 15 17:08:47 GMT 2023
|
Record UNII |
7WSK03KXXW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
656593
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
PRIMARY | |||
|
7WSK03KXXW
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
PRIMARY | |||
|
DTXSID40860428
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
PRIMARY | |||
|
SUB00923MIG
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
PRIMARY | |||
|
107080-63-7
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
PRIMARY | |||
|
C83569
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
PRIMARY | |||
|
100000084862
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
PRIMARY | |||
|
456
Created by
admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |